# John C.

John Campbell is a healthcare technology leader who writes about cybersecurity, AI governance, patient safety, and digital health from a healthcare CIO perspective.

- Profile: https://b2binfluencer.marketing/creators/john-c/
- LinkedIn: https://www.linkedin.com/in/johncampbell2025
- LinkedIn followers: 4,163
- Topics: artificial-intelligence, leadership, cybersecurity, healthcare, ai-governance
- Based on 14 dated posts, latest 2026-10-08

## Summary

Useful for CIO-level healthcare perspectives on cybersecurity, AI governance, patient safety, and board risk.

- Best for: Healthcare technology companies selling cyber resilience or AI oversight to healthcare executives.
- Not for: Consumer health or wellness campaigns needing mass reach, patient education, or packaged sponsorships.
- Check first: Ask for LinkedIn analytics or audience survey covering seniority, employer type, geography, and engagement.

### Takeaways

- Healthcare cybersecurity is a patient-safety and care-continuity problem, not an IT problem.
- AI governance needs risk-based approval, monitoring, security, vendor accountability, and human oversight.
- Board service changes the questions an executive asks about strategy, investment, risk, and leadership.

## Main ideas

- **Healthcare cybersecurity is a patient-safety and care-continuity problem, not an IT problem**: John Campbell argues that a cyberattack in healthcare can disrupt clinical workflows, delay access to critical information, interrupt revenue cycle operations, and affect connected medical technology. Cyber risk is therefore both an enterprise risk and a clinical risk. The leadership question is not only whether an attack can be prevented, but whether safe patient care can continue when one occurs. The answer, in the posts, depends on resilient architecture, strong identity controls, practiced incident response, business continuity, and leadership teams that also treat cyber risk as their responsibility.
- **AI governance has to work as an operating discipline, not a policy statement**: John Campbell argues that healthcare cannot afford to learn about AI safety through an adverse event. As AI becomes more capable and autonomous, failures can do more than produce inaccurate answers: they can expose patient information, influence clinical decisions, amplify bias, or automate actions without appropriate oversight. The proposed operating discipline has five parts: risk-based approval, continuous monitoring, strong cybersecurity, vendor accountability, and human oversight. The central claim is that adoption is not the open question; the question is whether governance and security can keep pace.
- **Current cybersecurity knowledge is table-stakes for a healthcare CIO**: John Campbell argues that connected medical devices, remote monitoring, cloud platforms, EHRs, virtual care, and AI have expanded both what healthcare technology can do and the surface an attacker can target. Security is no longer only the CISO's responsibility. A CIO should understand enough to ask the right questions about IoMT and medical device risk, identity and access management, Zero Trust, ransomware resilience, third-party and supply-chain risk, incident response and recovery, AI-enabled cyber threats, and clinical downtime. AI is advancing threats too quickly for leaders to rely on what they learned three, five, or ten years ago, so continuous learning is part of the job.
- **Board service changes the questions an executive asks**: John Campbell argues that sitting on a board of directors has been the most impactful leadership lesson of their career — more so than a healthcare CIO role or an MBA — because it shifts perspective. An executive inside a business asks how to deliver results in one part of it; a board member asks whether strategy is clear, investments are prioritized appropriately, risks are managed, the company is financially viable, the right leaders are being cultivated, and opportunities are being ignored. In this account, governance enables good decisions rather than creating bureaucracy, and board service makes John Campbell's recommendations more attentive to tradeoffs, risk, and strategic value.
- **Make technology risk legible to executives through short question lists**: A consistent method runs through the posts: translate a technical or industry topic into questions a healthcare CIO, executive, or board member should be able to ask. Cybersecurity becomes patient-safety questions; AI becomes governance questions; board service becomes decision-quality questions. This approach turns risk into something executives can act on without becoming specialists.

## Work to read

- [On AI governance in healthcare: "Innovation without guardrails is risk moving faster than accountability"](https://www.linkedin.com/posts/johncampbell2025_healthcareai-aigovernance-patientsafety-activity-7505235077593714688-Lima)
- ["In healthcare, cybersecurity is patient safety"](https://www.linkedin.com/posts/johncampbell2025_healthcarecybersecurity-cybersecurity-healthcareit-activity-7501041323127476224-rWrj)
- [Current cybersecurity knowledge as table stakes for the healthcare CIO](https://www.linkedin.com/posts/johncampbell2025_cpehome-activity-7496171315322658816-2l1Z)
- [The argument that board service makes better executives](https://www.linkedin.com/posts/johncampbell2025_leadership-boardgovernance-healthcareleadership-activity-7492262207926194177-w7Y5)
- [Speaking at ConV2X on health AI, digital health, and cybersecurity](https://www.linkedin.com/posts/johncampbell2025_digitalhealth-healthtech-healthcareinnovation-activity-7514021516167245826-51Z7)

## Brand relationships

- **University of Texas at Austin Center for Professional Education** (mention)
- **ConV2X** (mention)

## Partnerships

John Campbell's posts do not describe a partnership or sponsorship offer. Across five LinkedIn posts, they write as a healthcare technology leader about cybersecurity, AI governance, patient safety, and board governance; none describes a sponsored format, rate card, media kit, or bookable terms. The only public engagement activity is speaking: in an October post, they state they are a panelist at ConV2X SmartTech Transformation in Healthcare, held at the ILR Conference Center in New York City, covering health AI, digital health, and cybersecurity. The post shows willingness to appear on conference panels, but states no fee, deliverables, or booking process. A brand interested in working with them should ask directly through the LinkedIn profile, the only contact route stated in the posts, about sponsorship availability and terms.

## Alternatives

- Charles J. French: Choose Charles J. French when the buyer's problem is the voice channel, not broad AI governance: nuisance and deceptive calls flooding hospital phone lines, AI-powered vishing, deepfake voice fraud, and the patient-experience and reimbursement consequences. The posts offer concrete hooks for a board advisory or speaking session: unwanted calls as a clinical and HCAHPS/CMS problem, the claim that most hospitals have no technical defense on voice, and an example of Mutare's Voice Traffic Filter blocking 8,000 unwanted calls per day at one health system. That makes French a tighter fit than John Campbell for sessions on telephony security, vishing, or voice as an under-protected attack surface.
- Sana Dalvi: Choose Sana Dalvi when the buyer's task is adoption at the point of care: EHR implementation readiness, site visits, device and Wi-Fi gaps, clinical workflow realities, and multi-initiative fatigue during a documentation change. The posts offer practical detail for campaigns aimed at clinical informatics, nursing, and project-management audiences: device-to-user ratios of 1:3 at peak times, workarounds that have become permanent, missing backup power, and a change-management playbook built around trusted shift-level contacts, same-day availability, and one-page quick reference guides. For a healthcare technology company selling into health systems, that frontline angle can be more useful than a governance framework when the goal is adoption and go-live success.
- Suleman Adil CMgr FCMI: Choose Suleman Adil CMgr FCMI when the need is commercial: NHS and healthtech market entry, ambient voice technology adoption, procurement due diligence, retention risk, or go-to-market strategy. The posts offer a framework for judging AI adoption beyond pilot counts: utilization, clinician retention, time saved, integration, renewal, and evidence of value at 6, 12, and 24 months. They also identify warning signs of a weak healthtech business despite growing ARR and offer an independent commercial review. That fits companies seeking advice on their commercial model or a session for healthtech leadership teams, rather than a CIO-level governance keynote.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/